Skip to main content
. 2020 Nov 29;15(1):1184–1192. doi: 10.1515/med-2020-0241

Figure 1.

Figure 1

Clinical pathology and lncRNA UBE2R2-AS1 expression. Adjacent: adjacent normal tissues; I–II stage: I–II stage cervical cancer tissues; III–IV stage: III–IV stage cervical cancer tissues. (a) Clinical pathology by HE staining (200×) and lncRNA UBE2R2-AS1 mRNA expression. **P < 0.01 and ***P < 0.001, compared with NC group. (b) lncRNA UBE2R2-AS1 expression by ISH assay (200×) **P < 0.01, ***P < 0.001, compared with NC group.